.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Teva
AstraZeneca
Farmers Insurance
Mallinckrodt
US Army
Argus Health
US Department of Justice
QuintilesIMS
Harvard Business School

Generated: September 24, 2017

DrugPatentWatch Database Preview

OXYBUTYNIN Drug Profile

« Back to Dashboard

Which patents cover Oxybutynin, and what generic Oxybutynin alternatives are available?

Oxybutynin is a drug marketed by Barr Labs Div Teva, Mylan, Osmotica Pharm Us, Amneal Pharms, Silarx, Unique Pharm Labs, Usl Pharma, Zydus Pharms Usa Inc, Pharm Assoc, Accord Hlthcare, Mikart, Mylan Pharms Inc, Impax Pharms, Teva Pharms Usa, Wockhardt, Vintage Pharms, Watson Labs, Quantum Pharmics, and Apotex Inc. and is included in twenty-one NDAs.

The generic ingredient in OXYBUTYNIN is oxybutynin chloride. There are sixteen drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the oxybutynin chloride profile page.

Summary for Tradename: OXYBUTYNIN

Patents:0
Applicants:19
NDAs:21
Bulk Api Vendors: see list51
Clinical Trials: see list73
Patent Applications: see list2,951
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXYBUTYNIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET;ORAL072485-001Apr 19, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET;ORAL071655-001Nov 14, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET;ORAL072296-001Dec 8, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Wockhardt
OXYBUTYNIN CHLORIDE
oxybutynin chloride
SYRUP;ORAL074868-001Feb 12, 1997AARXNoYes► Subscribe► Subscribe► Subscribe
Barr Labs Div Teva
OXYBUTYNIN
oxybutynin
FILM, EXTENDED RELEASE;TRANSDERMAL090526-001Mar 4, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL207138-001Feb 29, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Pharms
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL076745-002May 9, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL204010-002Nov 23, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Osmotica Pharm Us
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL078503-002Feb 4, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Unique Pharm Labs
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL206121-003May 27, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
UBS
Medtronic
Chubb
Boehringer Ingelheim
Argus Health
Express Scripts
Cipla
US Department of Justice
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot